Compare HALO & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | FNB |
|---|---|---|
| Founded | 1998 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 6.8B |
| IPO Year | 2001 | 2002 |
| Metric | HALO | FNB |
|---|---|---|
| Price | $82.90 | $19.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $78.64 | $19.70 |
| AVG Volume (30 Days) | 1.7M | ★ 6.3M |
| Earning Date | 05-05-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.97% |
| EPS Growth | N/A | ★ 22.83 |
| EPS | ★ 1.22 | 0.38 |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | $14.12 |
| Revenue Next Year | $12.56 | $8.35 |
| P/E Ratio | $67.43 | ★ $50.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.23 | $14.46 |
| 52 Week High | $84.44 | $19.59 |
| Indicator | HALO | FNB |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 57.63 |
| Support Level | $67.63 | $16.95 |
| Resistance Level | $84.44 | $19.59 |
| Average True Range (ATR) | 2.03 | 0.36 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 76.24 | 71.43 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.